Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel hydrophilic surfactants derived from renewable chitin. Improved solubility and surface tension control for pharma and cosmetic applications via patented synthesis.
Patent CN114957170A reveals a cost-effective copper-catalyzed monofluoroolefination method offering superior Z-selectivity for reliable pharmaceutical intermediate manufacturing.
Patent CN110105355A reveals efficient one-pot synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN117700340B reveals homogeneous catalytic route for Iguratimod intermediate. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN102844314B details efficient Passerini reaction routes for protease inhibitors. Offers high purity pharmaceutical intermediates with streamlined synthesis and significant supply chain advantages for global partners.
Patent CN1119332C details a novel asymmetric hydrogenation route for azepine intermediates, offering cost-effective and scalable production for kinase inhibitors like Balanol.
Patent CN1265650A reveals a novel double-protection strategy for synthesizing 6-amino-3-azabicyclo[3.1.0]hexane derivatives, offering superior stereoselectivity and cost-effective routes for quinolone antibiotic manufacturing.
Patent CN102304095B details a novel 5-step synthesis for Sulfadoxine, eliminating toxic catalysts and improving purity for cost-effective pharmaceutical manufacturing.
Patent CN106755254B details a mild enzymatic route for lipoic acid sterol ester, offering high purity and yield for food and pharma applications.
Novel cobalt catalyst enables asymmetric hydroboration of mixed olefins. Delivers high enantioselectivity and substantial cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113200948A reveals a cost-effective copper-catalyzed route for chiral phthalides, offering high enantioselectivity and supply chain advantages for pharmaceutical manufacturers.
Patent CN1106395C details a novel asymmetric synthesis for IBAT inhibitor intermediates, offering superior stereocontrol and scalable manufacturing for pharmaceutical supply chains.
Patent CN106701698A reveals high-efficiency enzymatic synthesis for chiral alcohols. Offers cost reduction and high purity for pharmaceutical supply chains.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Patent CN106995374A reveals catalyst-free oxygen oxidation for nitroaromatic acids. Delivers high purity, cost reduction, and scalable supply chain solutions.
Patent CN107814824A reveals a noble-metal-free route for steroid intermediates. This ensures high purity and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN87100031A reveals microbial hydrolysis for high-purity S-Naproxen. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Novel hydrogenation method for 2-clopentylamino ethanol ensures high purity and cost efficiency. Ideal for reliable fine chemical intermediate supplier partnerships.
Patent CN102993224A reveals a novel synthesis for high-purity organic boron difluoride complexes, offering significant cost reduction in fluorescent material manufacturing.
Novel Strecker reaction route for Clopidogrel bisulfate. High yield, scalable process for pharmaceutical intermediates manufacturing.